Advanced Health Intelligence Ltd (AHI)
1.50
0.00 (0.00%)
USD |
NASDAQ |
Jul 01, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 11.66M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -60.84% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone. |
| URL | https://www.ahi.tech |
| Investor Relations URL | https://www.advancedhumanimaging.com/asx-investors |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Jul. 31, 2024 (est.) |
| Last Earnings Release | Jul. 31, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Advanced Health Intelligence Ltd (AHI) is engaged in developing and delivering user-friendly biometric scans to render vital signs and health risk estimates to a smartphone. By leveraging the smartphone with purpose-built computer vision, machine learning models, and patented algorithms, AHI provides a private and secure way for individuals to perform biometric health-risk assessment and stratification. AHI's technology delivers simple-to-use, scalable, and cost-effective means to enable individuals to check, track and act towards better health outcomes. The combination of the patented and proprietary BodyScan dimensioning and composition capabilities and, FaceScan to return vital signs enables a unique health assessment capability made accessible anytime, anywhere through the smartphone. |
| URL | https://www.ahi.tech |
| Investor Relations URL | https://www.advancedhumanimaging.com/asx-investors |
| HQ State/Province | N/A |
| Sector | Health Care |
| Industry | Health Care Technology |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Jul. 31, 2024 (est.) |
| Last Earnings Release | Jul. 31, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |